CDC ENTEBBE

LinusBio published research in The Lancet's eBioMedicine demonstrating a novel hair-based biomarker for ALS detection using copper-related elemental patterns.

A randomized clinical trial of 249 participants found that a single injection of benzathine penicillin G achieved 76% serologic response compared to 70% with the three-dose regimen at 6 months.

A qualitative analysis of the OPTIMIZE-CKD study found broad patient support for collaborative chronic kidney disease management between primary care providers and nephrologists.

pH-D Feminine Health has launched the first FDA-cleared Phase 3 clinical trial to validate boric acid suppositories as a treatment for yeast infections, marking a critical milestone in women's health research.

Leading medical organizations including the American Medical Association, American Academy of Pediatrics, and Infectious Diseases Society of America have been barred from CDC vaccine advisory workgroups.

Vaccine maker Bavarian Nordic has agreed in principle to a roughly $3 billion take-private offer from private equity firms Nordic Capital and Permira, with completion expected in the fourth quarter.

A federal judge has halted the Trump administration's mass layoffs at the Department of Health and Human Services, ruling the cuts likely violated federal law and caused irreparable harm.

A comprehensive CDC VISION Network study spanning over 345,000 emergency department encounters and 111,000 hospitalizations found that 2023-2024 COVID-19 vaccines reduced critical illness risk by 48% during the first seven to 299 days after vaccination.

Rutgers Health researchers found lamotrigine safe in older adults with epilepsy, contradicting a 2020 FDA safety warning about potential heart risks.

The Trump administration has terminated funding for multiple HIV vaccine research programs, including major efforts at Duke Human Vaccine Institute and Scripps Research Institute that have been running since 2012.